Supriya Lifescience Ltd (SPRL)

Currency in INR
716.05
-31.25(-4.18%)
Closed·
Earnings results expected today
SPRL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
710.00748.05
52 wk Range
556.15842.00
Key Statistics
Bid/Ask
716.05 / 720.80
Prev. Close
747.3
Open
744.6
Day's Range
710-748.05
52 wk Range
556.15-842
Volume
112.64K
Average Volume (3m)
230.04K
1-Year Change
2.2198%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SPRL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
940.00
Upside
+31.28%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Supriya Lifescience Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Supriya Lifescience Ltd Company Profile

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.

Employees
515
Market
India

Compare SPRL to Peers and Sector

Metrics to compare
SPRL
Peers
Sector
Relationship
P/E Ratio
31.6x34.4x−0.6x
PEG Ratio
1.960.700.00
Price/Book
5.3x2.7x2.6x
Price / LTM Sales
8.1x3.0x3.4x
Upside (Analyst Target)
31.3%34.0%41.8%
Fair Value Upside
Unlock5.5%4.8%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 940.00
(+31.28% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 22.69%
Dividend Yield
0.14%
Industry Median 0.75%
Annualized payout
1.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 12, 2025
EPS / Forecast
6.30 / --
Revenue / Forecast
2.00B / --
EPS Revisions
Last 90 days

SPRL Income Statement

People Also Watch

51.69
SAGL
-1.43%
7,198.50
CRAF
-5.57%
52.81
LLOS
-4.57%
410.20
KPIG
-5.59%

FAQ

What Is the Supriya Lifescience (SPRL) Stock Price Today?

The Supriya Lifescience stock price today is 716.05

What Stock Exchange Does Supriya Lifescience Trade On?

Supriya Lifescience is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Supriya Lifescience?

The stock symbol for Supriya Lifescience is "SPRL."

Does Supriya Lifescience Pay Dividends? What’s The Current Dividend Yield?

The Supriya Lifescience dividend yield is 0.14%.

What Is the Supriya Lifescience Market Cap?

As of today, Supriya Lifescience market cap is 57.63B.

What Is Supriya Lifescience's Earnings Per Share (TTM)?

The Supriya Lifescience EPS (TTM) is 22.69.

When Is the Next Supriya Lifescience Earnings Date?

Supriya Lifescience will release its next earnings report on Jan 26, 2026.

From a Technical Analysis Perspective, Is SPRL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Supriya Lifescience Stock Split?

Supriya Lifescience has split 0 times.

How Many Employees Does Supriya Lifescience Have?

Supriya Lifescience has 515 employees.

What is the current trading status of Supriya Lifescience (SPRL)?

As of Jan 26, 2026, Supriya Lifescience (SPRL) is trading at a price of 716.05, with a previous close of 747.30. The stock has fluctuated within a day range of 710.00 to 748.05, while its 52-week range spans from 556.15 to 842.00.

What Is Supriya Lifescience (SPRL) Price Target According to Analysts?

The average 12-month price target for Supriya Lifescience is INR940.00, with a high estimate of INR1030 and a low estimate of INR850. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +31.28% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.